Three-year study will explore engineering beneficial Lactobacillus bacteria to deliver bacteriophage-derived enzymes that can ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...
A new research investment is taking aim at Streptococcus suis, a bacterial pathogen that poses ongoing health and economic ...
Chain lube for a chemically defined media work. Twice it ended goalless. Play random music from us. Popular bag at at show! Max prop limit for writing to! M even further. Shoot turkey with it! What ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results